A review of comparison study between Corona Viruses (SARS-CoV, MERS-CoV) and Novel Corona Virus (Covid-19)

被引:6
|
作者
Al-Qahtani, W. S. [1 ]
Alneghery, L. M. [2 ]
Alqahtani, A. Q. S. [3 ]
AlKahtani, M. D. [4 ]
Alkahtani, S. [5 ]
机构
[1] Naif Arab Univ Secur Sci, Coll Criminal Justice, Dept Forens Sci, Riyadh, Saudi Arabia
[2] Al Imam Mohammad Ibn Saud Islamic Univ, Coll Sci, Dept Biol, Riyadh, Saudi Arabia
[3] Royal Commiss Hosp, Pharm Dept, Jubail Ind City, Saudi Arabia
[4] Princess Nourah Bint Abdulrahman Univ, Dept Biol, Coll Sci, Riyadh, Saudi Arabia
[5] King Saud Univ, Coll Sci, Dept Zool, Riyadh, Saudi Arabia
来源
关键词
SARS-CoV; SARS-CoV2 (COVID-19); Nidovirales; Pandemic; ACUTE RESPIRATORY SYNDROME; AMINOPEPTIDASE-N; FUNCTIONAL RECEPTOR;
D O I
10.24275/rmiq/Bio1692
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Currently (March 2020) COVID-19 disease has recorded the most significant number of deaths and cases as compared to coronaviruses' types. Initially, the virus was referred to as 2019-nCoV. Subsequently, the International Committee on Taxonomy of Viruses (ICTV) named it the SARS-CoV-2 virus because it is significantly similar to the causative agent of (SARS-CoVs). All Nidovirales' viruses are positive-sense non-segmented and enveloped viruses. They have big genomes for the RNA viruses. Coronavirinae has the most significant documented RNA genomes, having around 30 kilobases (kb) of genomes. The critical di fferences in the families of Nidovirus are noted in the type, sizes, and the number of structural proteins. The variances cause substantial alterations in the morphology and structure of the viruses and nucleocapsids. Currently, the COVID-19 diseases have recorded the most significant number of deaths and cases as compared to other kinds of coronaviruses. In conclusion, since the outbreak of (COVID-19) disease in China, the illness is spreading very quickly across the globe. There was no evidence showing that the viruses were manufactured in laboratories or engineered till now. Extensive lab work on the mechanisms of infection and genetic factors such as polymorphism that may play an essential role in disease is needed urgently.
引用
收藏
页码:201 / 212
页数:12
相关论文
共 50 条
  • [31] The corona virus SARS-CoV-2 and the pandemic Covid19
    Cossart, Pascale
    COMPTES RENDUS BIOLOGIES, 2021, 344 (01) : 1 - 5
  • [32] Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species
    Alharbi, Sultan Nafea
    Alrefaei, Abdulwahed Fahad
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2021, 33 (02)
  • [33] Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike
    Trigueiro-Louro, Joao
    Correia, Vanessa
    Figueiredo-Nunes, Ines
    Giria, Marta
    Rebelo-de-Andrade, Helena
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2020, 18 : 2117 - 2131
  • [34] The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus
    Wu, Zhonglan
    Harrich, David
    Li, Zhongyang
    Hu, Dongsheng
    Li, Dongsheng
    REVIEWS IN MEDICAL VIROLOGY, 2021, 31 (02)
  • [35] Are we neglecting MERS-CoV during COVID-19 pandemic: a need for refocusing on surveillance of the deadly MERS-CoV infection
    Mallhi, Tauqeer Hussain
    Khan, Yusra Habib
    Salman, Muhammad
    Butt, Muhammad Hammad
    CLINICAL MICROBIOLOGY AND INFECTION, 2024, 30 (02) : 256 - 257
  • [36] Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
    Hatmal, Ma'mon M.
    Alshaer, Walhan
    Al-Hatamleh, Mohammad A., I
    Hatmal, Malik
    Smadi, Othman
    Taha, Mutasem O.
    Oweida, Ayman J.
    Boer, Jennifer C.
    Mohamud, Rohimah
    Plebanski, Magdalena
    CELLS, 2020, 9 (12) : 1 - 37
  • [37] Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
    Yu, Sicong
    Che, Keda
    Fang, Lei
    Mao, Haiyan
    Lou, Xiuyu
    Li, Chaonan
    Zhang, Yanjun
    VACCINES, 2021, 9 (06)
  • [38] The Emergence of Novel SARS-CoV-2 (COVID-19) a Triple Reassortant Corona Virus Immunogenicity and Reactogenicity in Human
    Pradhan, Debasish
    Tripathy, Gitanjali
    Pradhan, Shaktiprasad
    Behera, Bandana
    Samantaray, Yasa
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2020, 14 (06) : LE01 - LE04
  • [39] Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives
    Barre, Annick
    Van Damme, Els J. M.
    Simplicien, Mathias
    Le Poder, Sophie
    Klonjkowski, Bernard
    Benoist, Herve
    Peyrade, David
    Rouge, Pierre
    CELLS, 2021, 10 (07)
  • [40] COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia
    Mazin Barry
    Maha Al Amri
    Ziad A. Memish
    Journal of Epidemiology and Global Health, 2020, 10 : 1 - 3